Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christoforos Meliadis has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Imaging- and Device-Based Congestion Assessment to Guide Chronic Heart Failure Management: A Systematic Review and Network Meta-Analysis

    by Michail Spanos, Dimitrios Raptis, Franco Joaquin Cossettini, Armend Balidemaj, Ashwin Ragupathi, Zainab Elahmadi, Joo Hee Park, Praveen Kumar Komminni, Ali Maaz, Pascal Ezerioha, et al.

    Background/Objectives: Congestion drives most heart-failure (HF) hospitalizations, and several strategies now titrate therapy to a directly measured congestion signal rather than to symptoms; whether they differ by the signal measured has not been examined comparatively. Methods: We performed a systematic review and contrast-based network meta-analysis of randomized trials comparing imaging- or device-based congestion-triggered management with usual care. Thirteen chronic-phase trials formed a star network (no closed loops; rankings exploratory) of four strategies, pressure-guided (N1), lung ultrasound (N2), transthoracic lung impedance (N3), and cardiac-implantable-electronic-device (CIED) intrathoracic impedance (N5), with HF hospitalization as the primary outcome and six prespecified sensitivity analyses; four acute trials formed a gap map. Results: Only pressure-guided monitoring reduced HF hospitalization (0.72, 95% confidence interval 0.57–0.90), stable across sensitivities and matching external data. Lung ultrasound did not reduce hospitalization (0.72, 0.48–1.08) or mortality but reduced urgent visits (0.26, 0.13–0.50). The apparent CIED-impedance harm (1.12, 0.77–1.63) reflected an audible-alert trial and dissolved when early-terminated trials were excluded (0.87). Lung impedance gave the largest estimate (0.51, 0.31–0.83) but rested on one trial. No strategy tested in more than one trial reduced mortality. Conclusions: The congestion signal acted upon, and who receives the alert, track with the effect, although signal and workflow cannot be separated within trials; clinicians should match modality to the intended outcome, as these tools defer hospitalization, not death.

  • Open Access

    Osteocyte-Intrinsic MMP13 exacerbates injury-induced temporomandibular joint osteoarthritis

    by Cristal S. Yee, Marianne Demirdji, Karsyn N. Bailey, Alena D. Larios, Christoforos Meliadis, Clarissa Aguirre Luna, Harrison B. Taylor, Peggi M. Angel, Sunil Kapila, Tamara Alliston


  • Open Access

    Estimating Maxillary Sinus Volume Using Smartphone Camera

    by Christoforos Meliadis, Emily Feng, Ezekiel Johnson, Wendy Zhu, Paramesh Gopi, Vivek Mohan, Peter H. Hwang, Jacob Johnson, Bryant Y. Lin

    Goal: This study aims to introduce a novel method for estimating maxillary sinus volume using smartphone technology, providing an accessible alternative to traditional imaging techniques. Methods: We recruited 40 participants to conduct a comparative analysis between Computed Tomography (CT) and face scans obtained using an Apple iPhone. Utilizing Apple's ARKit for 3D facial mesh modeling, we estimated sinus dimensions based on established craniofacial landmarks and calculated the volume through a geometric approximation of the maxillary sinus. Results: We demonstrated a high degree of agreement between CT and face scans, with Mean Absolute Percentage Errors (MAPE) of 8.006 ± 8.839% (Width), 6.725 ± 4.595% (Height), 9.952 ± 6.733% (Depth), and 10.429 ± 7.409% (Volume). These results suggest the feasibility of this non-invasive approach for clinical use. Conclusions: This method aligns with the growing focus on telemedicine, presenting significant reductions in healthcare costs and radiation exposure from CT scans. It marks a substantial advancement in otolaryngology and maxillofacial surgery, showcasing the integration of smartphone technology in medical diagnostics and opening avenues for innovative, patient-friendly, and cost-effective healthcare solutions.